2017 MDUFA Reauthorization Meetings Get Early Start

Anticipating delays typically experienced during  presidential elections, Congress and the U.S. Food and Drug Administration  (FDA) are starting the 2017 Medical Device User Fee Amendments (MDUFA)  Reauthorization negotiations nearly 2 years ahead of schedule.

This content is only available to members of the AAOS.

Please log in using the link at the top right corner of this page to access your exclusive AAOS member content.

Not a member? Become a member!

Advertisements


Advertisement